Your session is about to expire
← Back to Search
Behavioral Intervention
CONNECT Trial of eSupport Online Health-coach Moderated Support Groups for Multiple Sclerosis (CONNECT Trial)
N/A
Waitlist Available
Led By Victoria M Leavitt, Leavitt
Research Sponsored by eSupport Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, 20-40 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests an online support group for adults with MS, especially Black and Latinx individuals. The sessions are led by a therapist and aim to improve mental health through mutual respect and trust.
Eligible Conditions
- Multiple Sclerosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, 20-40 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, 20-40 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adherence and completion
Secondary study objectives
Hospital Anxiety and Depression Scale (HADS)
Other study objectives
Functional Assessment in MS (FAMS)
Treatment adherence / healthcare utilization
UCLA Loneliness Scale Version 3
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: PwMS eSupport GroupsExperimental Treatment1 Intervention
12-weeks active treatment of eSupport Health's Weekly Group Sessions, a formal semi-structured program of psychoeducational support delivered in a small group format by licensed therapists who specialize in MS. The active treatment period will follow a 12-week waitlist period that will be used to enable a within-subject control design. Note that the very first group enrolled (N\~10) will not have a 12-week waitlist period but will instead enter directly into the 12-week treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eSupport Health Weekly Group Sessions for PwMS
2021
N/A
~60
Find a Location
Who is running the clinical trial?
eSupport HealthLead Sponsor
Victoria M Leavitt, LeavittPrincipal InvestigatoreSupport Health, PBC